Drug Trial Radar · NCT05122182
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Last checked: Nov 19, 2026Latest source record: Sep 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
49
Actual
Start
Jan 7, 2022
Primary completion
Aug 15, 2022
Study completion Jan 28, 2023
Sponsor
- Lead sponsor
- University of SydneyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The George Institute
- First posted
- Nov 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CLARITY 2.0 is an investigator-initiated trial that will evaluate the safety and efficacy of dual treatment with repagermanium, a CCR2 antagonist, and candesartan, an ARB, in patients hospitalised with COVID-19 disease.
Conditions
- COVID-19
- SARS-CoV2 Infection
Interventions
Candesartan CilexetilDrug
Angiotensin Receptor Blocker (ARB)
RepagermaniumDrug
C-C chemokine receptor type 2 (CCR2) antagonist
Candesartan PlaceboDrug
Angiotensin Receptor Blocker (ARB) placebo
Repagermanium PlaceboDrug
C-C chemokine receptor type 2 (CCR2) antagonist placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Health Score at day 14Time frame: 14 days
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Jawaharlal Nehru Medical College and Hospital
Aligarh, India
Government Medical College and Hospital
Chandigarh, India
Samishta Hospital and Research Institute
Guntur, India
Maharaja Agrasen Hospital
Jaipur, India
Amrita Institute of Medical Science
Kochi, India
Kasturba Medical College
Mangaluru, India
DM Wayanad Institute of Medical Sciences
Meppādi, India
Sterling Hospital
Nigdi, India
Jivanrekha Multi-Speciality Hospital
Pune, India
All India Institute of Medical Sciences, Raipur
Raipur, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.